Crossmark

Discontinuation of antidepressant medication in primary care supported by monitoring plus mindfulness-based cognitive therapy versus monitoring alone: design and protocol of a cluster randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s12875-019-0989-5

Published Online: 2019-07-26

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wentink, Carolien https://orcid.org/0000-0001-9521-4105
Huijbers, Marloes J.

Lucassen, Peter

Kramers, Cornelis

Akkermans, Reinier

Adang, Eddy

Spijker, Jan

Speckens, Anne E. M.
Funding

Funding for this research was provided by:

Dutch Health Care Insurers Innovation (3.048)
License Information

Text and Data Mining valid from 2019-07-26

Version of Record valid from 2019-07-26
More Information

Article History

Received: 19 December 2017

Accepted: 4 July 2019

First Online: 26 July 2019

Ethics approval and consent to participate

: The ethics approval and consent to participate have been given by the medical ethics committee Arnhem-Nijmegen (METC-AN) and are registered for this study protocol under number 2016–2527. Written informed consent from participating patients, that has been approved by the METC-AN, will be obtained.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below